To evaluate the effectiveness of a collaborative goal-setting intervention (Empowering Patients in Chronic Care [EPIC]) to improve glycaemic control and diabetesrelated distress, and implementation into routine care across multiple primary care clinics.
| INTRODUC TI ON
Diabetes mellitus is a global epidemic affecting more than 380 million individuals. 1 Individuals with diabetes often struggle to make the behavioural and lifestyle changes necessary to prevent diabetes complications. 2 Diabetes care experiences often carry a high emotional burden leading to worry and distress associated with diabetes self-care. 3 Furthermore, patients with high levels of diabetes-related distress are significantly more likely to have poor glycaemic control, self-care and quality of life. 3 Identifying and implementing effective behavioural change interventions into routine practice is essential and requires the engagement of a coordinated, interprofessional team that supports patients. 4 Goal-setting promotes diabetes control by improving self-management behaviours and trust in one's clinicians. 5 Collaborative goal-setting is an evidence-based, behaviour change strategy for improving diabetes outcomes in primary care. 6 Empowering Patients in Chronic Care (EPIC) is a patient-centred intervention that uses collaborative goal-setting to improve diabetes outcomes. EPIC uses a group-based approach and motivational interviewing techniques to activate patients, 7 guide them in setting diabetes goals and action plans, 6 develop skills to communicate goals with healthcare providers, 8 and negotiate action plans to achieve their goals. 5 An efficacy study demonstrated that EPIC significantly improved haemoglobin A 1c (HbA 1c ) levels compared with usual diabetes care plus diabetes and nutrition education. 7 Moreover, EPIC sustained significant HbA 1c improvements over 12 months, contrasting many diabetes education and self-management interventions that experience significant regression to mean after 4 months. 9 Translating behaviour change interventions into routine primary care can be challenging. Barriers to implementation include economic disincentives, administrative burdens, education and time pressures. 10 The patient-centred medical home is a model of primary care designed to address some of these barriers using behavioural and systems-based methods to activate and empower patients and coordinate interprofessional teams to improve chronic illness care. 11 Building on the prior evidence-base for the EPIC intervention, we partnered with a large health system implementing a patient-centred medical home model to conduct a randomized clinical effectiveness trial of the EPIC intervention embedded across several of its primary care networks. 12 The aims of this trial are to evaluate: (a) the clinical effectiveness of EPIC to improve diabetes control and reduce diabetes-related distress among adults with diabetes, and (b) the implementation of EPIC in several primary care practices. We hypothesized that patients who received EPIC would have significant improvements in HbA 1c and diabetes distress levels post-intervention and that these effects would be sustained 10-months after enrolment.
Empowering Patients in Chronic Care is unique in that it combines group-based intervention with individual 1:1 immediate attention following each group-based intervention. Moving an intervention from laboratory to "real world" is a complex process. The current protocol allows for testing the effectiveness of EPIC when delivered by nonacademic providers in routine primary care across multiple clinic sites. Because each clinic has its own culture and ways of delivering primary care that may interfere with fidelity of the intervention, EPIC needs to be tested per the presented protocol to evaluate its effectiveness as it moves towards wider implementation.
| ME THODS

| Study design
The overall study is a hybrid type 1 implementation/effectiveness trial of the EPIC intervention. Per Curran and Bauer, 13 a hybrid trial type 1, aims to determine the effectiveness of a clinical intervention and better understand context for implementation. The current study protocol is designed to evaluate the effectiveness of EPIC on diabetes outcomes, specifically change in haemoglobin A1c and diabetes distress levels. To further understand the context of EPIC's implementation across five geographically distinct clinics consisting of a formative (phase 1) and summative (phase 2) evaluation of implementation, qualitative data collected from clinicians and participants will increase understanding of barriers and facilitators to implementation of EPIC in routine clinical practice and ultimately 
Novelty Statement
• This protocol describes a study to evaluate the realworld effectiveness of an innovative collaborative goal-setting intervention and glycaemic control and patient-reported diabetes distress. enhance clinical implementation. The first phase focused on evaluating providers' readiness for change at each study site and is described in detail elsewhere. 12 Key informants were interviewed to identify healthcare providers' perceptions of training for conducting the EPIC programme. They also informed the research team on how best to integrate the intervention into routine clinic flow.
Recommendations from this formative evaluation guided the overall implementation of the clinical trial and training of clinicians across all sites. 12 The current protocol describes a randomized clinical trial comparing the EPIC intervention with enhanced usual care (EUC).
| Study setting and ethics review
We recruited participants from three hospital-based primary care clinics and two community-based outpatient clinics. The clinics are part of two distinct regional networks of the United States 
| Participants
| Practice-based health professionals
We recruited healthcare providers (HCPs) that included physicians, nurses, dieticians, pharmacists and primary care mental health providers from each intervention site. The diversity in HCP background/ discipline most likely resembles conditions that EPIC will encounter as it moves from controlled laboratory setting to every day, realworld settings. Although participation was completely voluntary, we encouraged participation from clinicians who already provided diabetes self-management support and/or had prior training in health behaviour change methods. We enrolled three to five HCPs at each average competence was 6.1, which is in the "good" range on our predetermined scale.
| Participant recruitment
Our intervention was designed for individuals with uncontrolled diabetes despite having access to primary care and evidence-based therapies. We started with a population-screening approach to identify all individuals with uncontrolled diabetes within each of the clinics' known patient panels. Using limited exclusion criteria, we then attempted to enrol as many participants who met this inclusion criteria as possible. We mailed and then called all patients meeting our eligibility criteria with approval/support from clinic staff. Our recruitment strategy was selected to provide the broadest potential reach among patients meeting our eligibility criteria 16 (Table 1) .
Study participants were recruited from five total community-based clinics in urban, suburban and rural settings that varied in size.
Patient population within these clinics is mostly older males; however, the makeup is diverse by education, race and ethnicity. We set a target number of participants to recruit at each of the intervention sites. Each site met their recruitment targets within the recruitment timeframe. We randomized participants in random blocks of 4, 6 or 8 equally between the study arms using SAS.
Participants were clustered into groups of approximately six for delivery of the EPIC intervention. The final sample size was 280. 
| Procedures
| EPIC intervention
| Enhanced usual care
| Primary outcome measurements
| Effectiveness outcomes
To measure effectiveness and maintenance of the intervention, this study will examine two primary outcomes post-intervention 
| Implementation outcomes
Outcomes for EPIC implementation will be assessed using dimensions from the RE-AIM Framework 19 as described in Table 1 . Reach is the proportion of the eligible population that participated in the study. Adoption is defined as the proportion of providers who used the intervention and the number of individuals who participated in the intervention. Implementation is the extent to which the intervention is delivered as prescribed. These constructs will be operationalized by tracking the number of participants who were eligible for and participated in the study, the number and type of HCPs who took part in EPIC training, and the number of group sessions attended per patient.
| Procedure
Blinded research staff collected data at baseline, post-intervention, and 6 months after the intervention (ie, maintenance, occurring 10 months after baseline), with parallel time points in the EUC condition. The baseline self-report assessments were collected in person;
however, the remaining two assessments were mailed to participants. Research staff scheduled laboratory visits for HbA 1c within 2 weeks of the target data collection time.
Participants received compensation of $25 after HbA 1c results and self-report assessments were collected at each time point. Study staff also performed chart abstraction to obtain clinical and service utilization data, including blood pressure, body mass index, last primary care visit date and active medications. We anticipated the rates of missing data for primary outcomes would be <20%.
| Data analysis
| Effectiveness and maintenance analysis
Primary outcome analyses at post-intervention will be intention-totreat (ITT) and will use multiple imputation procedures PROC MI and MI ANALYZE in SAS version 9.4. If intraclass correlation coefficients (ICCs) for HbA 1c and DDS reveal that the degree of total variance explained by variance between cohorts and between sites is low (ie, ICCs <.05), Analysis of Covariance (ANCOVA) will be employed to examine treatment differences in outcomes immediately post-intervention (at 4 months). However, if ICCs reveal an adequate degree of between-cohort or between-site variance in HbA 1c or DDS (ie, ICCs >.05), we will employ multilevel modelling using PROC Mixed in SAS to account for the dependency of observations in the data. With either approach, two models will be conducted: one with HbA 1c postintervention as the outcome and one with DDS at post-intervention as the outcome. Models will include treatment group (ie, EPIC vs EUC) as a predictor and respective HbA 1c or DDS baseline scores and any demographic or clinical variables that differed between the study arms at baseline as covariates. Treatment effect sizes will be calculated post-intervention. If multilevel models are warranted, participants will be the level 1 unit, which will be nested within cohorts (level 2) which will be nested within sites (level 3). An unstructured covariance structure type will be specified. Analyses for examination of maintenance of treatment effects will be similar to those for immediate treatment effects post-intervention. Analyses will be intent-to-treat and either ANCOVA or multilevel models will be employed to examine treatment differences in outcomes at the maintenance assessment (6-months post-intervention). Two models will be conducted: one with HbA 1c at 6-months post-intervention as the outcome and one with DDS at 6-months post-intervention as the outcome. Models will include treatment group (EPIC vs EUC) as a predictor and respective HbA 1c or DDS scores and any demographic or clinical variables that differed between the study arms at baseline as covariates. Treatment effect sizes will be calculated at the 6 months post-intervention.
F I G U R E 2
| Reach, adoption and implementation analyses
We will calculate descriptive statistics such as frequencies, proportions, means and standard deviations for characteristics of the overall sample and for each specific facility.
We will assess reach by comparing the per cent of enrolled study participants compared with all potentially eligible patients in the given clinic population. To assess EPIC adoption, we will use descriptive statistics including the frequency and percentage of different professional disciplines among all healthcare providers who participated in the intervention. Adoption will also include number of sessions (group and individual) that were conducted vs the number that was prescribed by site.
To examine implementation of the intervention, a behavioural coaching expert will listen to audio recordings of each site's first group and 20% of group recordings thereafter. We will assess adherence and competency of HCPs who completed training in EPIC using a previously developed and validated instrument. 20 Additional measures for intervention fidelity will include an attendance ratio consisting of the total possible number of group sessions (six) as the denominator and the proportion of individual sessions attended per patient (ie 0-6) as the numerator. The study staff also will also measure participants' self-reported ratings of how well their group leader and individual session provider(s) engaged them in goal-setting using a validated measure 21 and ratings of goal and action plan quality using our previously validated rating Goal Evaluation Tool-Diabetes (GET-D) tool. 22 
| RE SULTS
Data analyses for effectiveness and implementation are pending.
However, as indicated in Table 2 ). The only exception is that the number of participants with prior diabetes education was greater for participants in the EUC arm compared with the EPIC arm, χ 2 (1, N = 280) = 8.44, P = .00. Table 3 : 65% of EPIC-trained providers reported having 10 or more years of practice experience; 80% reported counselling and 62% reported clinical management as part of their regular activities; 62% were trained in motivational interviewing prior to EPIC participation.
| D ISCUSS I ON
The current study is a multisite, randomized clinical trial evaluating real-world effectiveness and implementation of a collaborative goalsetting intervention using practice-based healthcare professionals in routine primary care settings. If evidence supports improvement in diabetic outcomes in this "real-world" trial, then EPIC could be a viable, innovative strategy to improve the standard of care in diabetes self-management.
Testing interventions delivered by practice-based (not research-based) healthcare professionals at multiple sites are logistically more complex and require significantly greater resources. We partnered with HCPs and clinic administrators to assess openness to adoption of EPIC. 12 We assessed the local culture, context and ex- 
| Potential limitations
There are several potential limitations to our protocol that we will need to consider in our analysis of the trial. One potential limitation Also, to ensure that participants would be able to actually participate in the group-based intervention and prevent hypoglycaemic episodes in those at high risk for it, a number of exclusion criteria were listed. As EPIC continues down the path towards implementation, the intervention will inherently be tested under increasing less rigid environments.
| Theoretical foundations
The EPIC intervention builds on a conceptual model of collaborative decision-making among patients and their healthcare providers. 7 The basis for these decisions is rooted in what matters most to patients in their health. 24 The EPIC intervention begins by exploring why controlling diabetes is personally important to each participant and then focuses on behavioural changes patients are willing to make to control their diabetes, taking into account patient care preferences. 7, 20 EPIC sessions also focus on understanding how the disease burden of uncontrolled diabetes can impede a patient's ability to live in accord with one's values. 25 Empowering Patients in Chronic Care introduces the concept of goals and goal-setting adapted from the organizational psychology literature. 26 
TA B L E 3 Characteristics of intervention sites
and proactive communication with one's healthcare providers is often an essential step in the process of developing effective health goals. 8 EPIC includes a video-guided exercise that activates patients to communicate collaboratively with their healthcare providers (ie, Speak-Up) and teaches communication skills to improve care. Once patients define their healthcare goals, they must develop action plans to help them achieve their goals and monitor their own progress towards achieving goals. The EPIC intervention concludes with ongoing encouragement to iteratively refine and achieve one's behavioural goals by working through one or more action plans. In addition to guidance from EPIC clinicians, membership within cohorts remain static throughout the intervention, facilitating peer support for problem solving and goal attainment among group participants. 7
| CON CLUS ION
As the prevalence of and sequelae of diabetes continue to rise, it is 
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